NCT03147352View on ClinicalTrials.gov

Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study

CompletedOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Necrotizing Soft Tissue InfectionNecrotizing FascitisGas GangreneFournier Gangrene
Interventions
DEVICE

Hyperbaric oxygen therapy

Hyperbaric oxygen therapy with 100 % oxygen at 1.8 ATA for 2 hours.

Trial Locations (1)

2100

Copenhagen University Hospital, Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Seventh Framework Programme

OTHER

lead

Ole Hyldegaard

OTHER

NCT03147352 - Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study | Biotech Hunter | Biotech Hunter